Episode #2, June 2021
Welcome to Blood Flow where we discuss contemporary evidence in cardiovascular disease management and how to improve outcomes for patients. View archived episodes at veslcommunity.org/blood-flow
In this Episode #2 of Blood Flow
, Dr. Liam Brunham
reviews a section of the 2021 Canadian Dyslipidemia Guidelines addressing non-statin treatments for LDL-C and when to use them
>> View the video
Do you have questions about this video? Ask your question in the VESL community on Sosido
Forgot your password?
You can instantly reset your password
The VESL community is designed for the scientific exchange of information between Healthcare Professionals and is made possible with financial support from Novartis Canada. Novartis does not itself monitor the discussions. However a third-party service provider does review the discussions only for the purpose of identifying any potential AE discussion. This review is required since as a drug manufacturer, Novartis has a regulatory obligation to report any AE that (directly or indirectly) comes to their attention. The third-party will only report the potential AE discussion and will include contact information. Should your post be reported to patient safety, you will be contacted by the third-party service provider to determine if you would like Novartis patient safety to contact you for more details.